Brian P. Chekal - Concepedia

Author

Brian P. Chekal

Pfizer (United States)

Also Known As

Brian Chekal, Brian P. Chekal, Chekal, B.P.

Publications

358

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)Pfizer (United Kingdom)

About

Brian P. Chekal is an author at Pfizer (United States) specializing in engineering, chemistry, and materials science.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	6	6	221
2	Medicine	2	2	153
3	Natural Sciences	2	2	83
4	Biochemistry	2	2	83
5	Applied Physics	1	1	34

Brian P. Chekal

Publications

356

Citations

H-Index

Page 1

	Year	Citations
Development of a Targeted Polymorph Screening Approach for a Complex Polymorphic and Highly Solvating API Anthony M. Campeta, Brian P. Chekal, Yuriy A. Abramov, Journal of Pharmaceutical Sciences Mutation-based TestingFunctional GenomicsMedicineGeneticsComputational Biology	2010	135
The Challenges of Developing an API Crystallization Process for a Complex Polymorphic and Highly Solvating System. Part I Brian P. Chekal, Anthony M. Campeta, Yuriy A. Abramov, Organic Process Research & Development X-ray CrystallographyCrystal StructureEngineeringChemistrySoft Matter	2009	69
Development of an Efficient Pd-Catalyzed Coupling Process for Axitinib Brian P. Chekal, Steven M. Guinness, Brett M. Lillie, Organic Process Research & Development Materials ScienceMigita CouplingChemical EngineeringCross-coupling ReactionEngineering	2013	66
Relationship between Chain Length and the Concentration Dependence of Polymer and Oligomer Self-Diffusion in Solution Brian P. Chekal, John M. Torkelson Macromolecules Chemical KineticsEngineeringChemistryPolymersChain Length	2002	34
A Thermodynamic-Based Approach to Analyzing a Highly Solvating Polymorphic System: The Desolvation Window Method Brian Samas, Christopher Seadeek, Anthony M. Campeta, Journal of Pharmaceutical Sciences Thermodynamic-based ApproachThermodynamic ModellingEngineeringEntropyEquilibrium Thermodynamics	2010	20
Palbociclib Commercial Manufacturing Process Development. Part III. Deprotection Followed by Crystallization for API Particle Property Control Brian P. Chekal, Jason Ewers, Steven M. Guinness, Organic Process Research & Development Combinatorial ChemistryPharmaceutical ScienceEngineeringPart IiiIndustrial Engineering	2016	18
Development of the Commercial Route for the Manufacture of a 5-Lipoxygenase Inhibitor PF-04191834 Brian P. Chekal, David B. Damon, Danny Lafrance, Organic Process Research & Development EngineeringOrganic ChemistryChemistryPharmaceutical ChemistryMedicinal Chemistry	2015	14

Page 1